f520
Showing 1 - 5 of 5
Solid Tumors Trial in Chongqing (F520, Lenvatinib)
Recruiting
- Solid Tumors
- F520
- Lenvatinib
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Feb 13, 2023
NSCLC, NSCLC, PD-1 Trial in Beijing (F520, Pemetrexed, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- +2 more
- F520
- +3 more
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Feb 22, 2023
Locally Advanced or Metastatic Urothelial Cell Carcinoma Trial (F520)
Not yet recruiting
- Locally Advanced or Metastatic Urothelial Cell Carcinoma
- F520
- (no location specified)
Nov 18, 2020
Peripheral T Cell Lymphoma Trial (F520)
Not yet recruiting
- Peripheral T Cell Lymphoma
- F520
- (no location specified)
Oct 19, 2020
Primary CNS Lymphoma, Secondary CNS Lymphoma Trial (F520)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- F520
- (no location specified)
Oct 19, 2020